SHANGHAI, CHINA and CAMBRIDGE, MASSACHUSETTS, US, October 27, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and com...
April 2022: Pembrolizumab (Keytruda, Merck) was approved by the Food and Drug Administration as a single agent for patients with advanced endometrial carcinoma that is microsatellite instability-high...
A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online version on November 8, 2017. doi: 10.1182 / blo...
Researchers at the University of New South Wales in Sydney and the California Institute of Biomedicine (CALIBR) have demonstrated that "specially cultured killer cells" can be used to treat pancreatic...
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs ...
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcin...
The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal...
July 2021: In June 2014, KITE Biotechnology Company, with only 19 employees, was listed on NASDAQ in the United States, and it took 130 million US dollars in one day! Just two months later, Juno Bio...
Proton therapy in astrocytma was tried in 2012 for the first time.In 2012, Annabelle was diagnosed with fibroblastic astrocytoma, a brain tumor. Surgery removed most of the tumor but unfortunately th...
July 2021: CAR T-Cell therapy in solid tumors has been approved in China with certain indications and markers. Recently, CAR T-Cell therapy is been tested for solid cancers like : Breast cancer ...